Corrigendum to "Tuftsin-phosphorylcholine attenuate experimental autoimmune encephalomyelitis" [J Neuroimmunol. 2019 Dec 15;337:577070. doi: 10.1016/j.jneuroim.2019.577070. Epub 2019 Oct 24]

Affiliations

• ¹ Laboratory of Mosaic of Autoimmunity, Saint Petersburg State University, St. Petersburg, Russian Federation; Department of General Pathology and Pathophysiology, FGBNU "Institute of Experimental Medicine", St. Petersburg, Russian Federation.
• ² St George's, University of London MBBS programme at the University of Nicosia Medical school, Cyprus, in Collaboration with Sheba Medical Center, Israel.
• ³ Zabludowicz Center for Autoimmune Diseases, Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
• ⁴ Laboratory of Mosaic of Autoimmunity, Saint Petersburg State University, St. Petersburg, Russian Federation.
• ⁵ Laboratory of Mosaic of Autoimmunity, Saint Petersburg State University, St. Petersburg, Russian Federation; Zabludowicz Center for Autoimmune Diseases, Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
• ⁶ Department of Immunology, The Weizmann Institute of Science, Rehovot 761001, Israel.
• ⁷ Zabludowicz Center for Autoimmune Diseases, Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Internal Medicine B and Zabludowicz Center for Autoimmune Diseases, Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: howard.amital@sheba.health.gov.il.